The learning curve of laparoscopic liver resection utilising a difficulty score
, , , , , y | 06 sept 2021
Acerca de este artículo
Article Category: Research Article
Publicado en línea: 06 sept 2021
Páginas: 111 - 118
Recibido: 02 jun 2021
Aceptado: 16 jul 2021
DOI: https://doi.org/10.2478/raon-2021-0035
© 2022 Arpad Ivanecz, Irena Plahuta, Matej Mencinger, Iztok Perus, Tomislav Magdalenic, Spela Turk, Stojan Potrc, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1
Figure 2
Figure 3
Figure 4
Baseline characteristics of 171 patients who underwent laparoscopic liver resection
| Baseline characteristics | Na,b |
|---|---|
| Male sexa | 104 (60.8%) |
| Age (years)b | 64 (20-86, 15) |
| BMI (kg/m2)b | 27 (18-50, 4.8) |
| 1 44 (25.7%) | |
| ASA scorea | 2 73 (42.7%) |
| 3 51 (29.8%) | |
| 4 3 (1.8%) | |
| Liver cirrhosis Child-Pugh (22)a | A 33 (19.3%) |
| B 4 (2.3%) | |
| Previous abdominal surgerya | 41 (24.0%) |
| Previous liver resectiona | 8 (4.6%) |
| Malignant tumoura | 128 (74.9%) |
| Neoadjuvant chemotherapya | 25 (14.6%) |
| Max. diameter (mm)b | 38 (2-160, 33) |
| Number of tumoursa | 1 (1-10, 0). |
| Deep location within livera | 50 (29.2%) |
| Posterosuperior liver segmentsa | 49 (28.7%) |
Perioperative outcomes of 171 patients who underwent laparoscopic liver resection
| Intraoperative details and postoperative course | Na,b |
|---|---|
| Anatomic resection (23) a | 101 (59.1%) |
| Anatomically major resection (23) a | 27 (15.8%) |
| Technically major resection (24)a | 29 (17.0%) |
| Operation time (min)b | 160 (25-450, 90) |
| Blood loss (mL)b | 150 (0-2200, 180) |
| Intraoperative complication (10)c | |
| Conversion to open approacha | 24 (14.0%) |
| Blood loss > 775 mLa | 12 (7.0%) |
| Unintentional damage to the surrounding structuresa | 2 (1.2%) |
| Hepatic pedicle clampinga | 45 (26.3%) |
| Total hepatic pedicle clamping time (min)b | 8 (0-75, 10) |
| Transfusion requireda | 20 (11.7%) |
| Pathohistological diagnosis | |
| Colorectal liver metastases | 53 (31%) |
| Hepatocellular carcinoma | 46 (29.6%) |
| Intrahepatic cholangiocarcinoma | 14 (8.2%) |
| Other metastases | 11 (6.4%) |
| Hepatic cysts | 10 (5.8%) |
| Hepatic adenoma | 6 (4.7%) |
| Focal nodular hyperplasia | 8 (4.7%) |
| Haemangioma | 6 (3.5%) |
| Other pathology | 15 (8.8%) |
| R0 resection | 163 (95.3%) |
| Major morbidity CD 3a–4b (25)a | 21 (12.3%) |
| Hospital stay (days)b | 6 (2-79, 4) |